Inicio › Cáncer de páncreas › Virginia › Arlington
Ensayos clínicos de Cáncer de páncreas en Arlington, VA
33 estudios para Cáncer de páncreas buscan participantes en centros de Arlington y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
The Vanguard Study: Testing a New Way to Screen for Cancer
ReclutandoSe aceptan voluntarios sanos
- Inova Schar Cancer Institute, Fairfax · A 11 mi de distancia
- Inova Fair Oaks Hospital, Fairfax · A 11 mi de distancia
Atebimetinib + GnP as a First Line Treatment in Patients With Metastatic Pancreatic Adenocarcinoma
ReclutandoFase 3
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
Phase 1/2 Study of BHB810 in Advanced Gastric and GEJ Adenocarcinoma
ReclutandoFase 1/2
- NEXT Virginia, Fairfax · A 11 mi de distancia
A Study of PHN-012 in Patients With Advanced Solid Tumors
ReclutandoFase 1
- PHN-012-001 Site, Fairfax · A 11 mi de distancia
A Study of IDE892 as Monotherapy and Combination in MTAP-deleted Advanced Solid Tumors
ReclutandoFase 1
- NEXT Oncology Virginia, Fairfax · A 11 mi de distancia
Study of Daraxonrasib (RMC-6236) in Patients With Resected Pancreatic Ductal Adenocarcinoma (PDAC)
ReclutandoFase 3
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
A Study to Evaluate Chemotherapy With or Without INCB161734 in Previously Untreated, KRAS G12D-Mutated Metastatic Pancreatic Ductal Adenocarcinoma
ReclutandoFase 3
- Investigative Site US057, Fairfax · A 11 mi de distancia
- Investigative Site US065, Fairfax · A 11 mi de distancia
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
ReclutandoFase 3
- Inova Schar Cancer Institute Clinical Trials, Fairfax · A 11 mi de distancia
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
ReclutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
ReclutandoFase 1/2
- NEXT Oncology Virginia, Fairfax · A 11 mi de distancia
A First-in-Human Trial of BLU-924 (SAR449336) in Advanced Solid Tumors Harboring KRAS Mutations
ReclutandoFase 1/2
- Next Oncology Virginia Cancer Specialist, Fairfax · A 11 mi de distancia
Study of RMC-5127 in Patients With Advanced KRAS G12V-Mutant Solid Tumors
ReclutandoFase 1
- NEXT - Virginia, Fairfax · A 11 mi de distancia
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
ReclutandoFase 1
- NEXT Oncology, Fairfax · A 11 mi de distancia
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
ReclutandoEstudio observacional
- Inova Fairfax Hospital, Falls Church · A 4 mi de distancia
- Inova Schar Cancer Institute, Fairfax · A 11 mi de distancia
- Inova Fair Oaks Hospital, Fairfax · A 11 mi de distancia
A Phase 2 Study of VS-7375 in Patients With KRAS G12D-Mutated Pancreatic Cancer
ReclutandoFase 2
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
Phase 1 Study of MRTX1719 in Solid Tumors With MTAP Deletion
ReclutandoFase 1
- Virginia Cancer Specialists, PC, Fairfax · A 11 mi de distancia
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
ReclutandoFase 3
- Inova Fairfax Hospital, Falls Church · A 4 mi de distancia
- Inova Schar Cancer Institute, Fairfax · A 11 mi de distancia
- Inova Fair Oaks Hospital, Fairfax · A 11 mi de distancia
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
ReclutandoFase 1
- NEXT Virginia, Fairfax · A 11 mi de distancia
Pancreatic Cancer Early Detection Consortium
ReclutandoEstudio observacionalSe aceptan voluntarios sanos
- Inova Schar Cancer Institute, Fairfax · A 11 mi de distancia
A Study of PT0511 in Participants With KRAS Mutated or Amplified Advanced Solid Tumors
ReclutandoFase 1
- NEXT Virginia, Fairfax · A 11 mi de distancia
A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation
ReclutandoFase 1
- NEXT Virginia, Fairfax · A 11 mi de distancia
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
ReclutandoFase 1
- Virginia Cancer Specialists - Fairfax /ID# 232592, Fairfax · A 11 mi de distancia
A Study to Learn About Study Medicine ALTA3263 in Adults With Advanced Solid Tumors With KRAS Mutations
ReclutandoFase 1
- Research Site, Fairfax · A 11 mi de distancia
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
ReclutandoFase 1
- NEXT Oncology Virginia, Fairfax · A 11 mi de distancia
A Study to Evaluate the Safety, Tolerability, and Efficacy of BMS-986523 Alone and in Combination With Anti-Cancer Agents in Participants With Advanced Solid Malignancies
ReclutandoFase 1/2
- NEXT Virginia, Fairfax · A 11 mi de distancia
Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations
ReclutandoFase 3
- Inova Schar Cancer Institute, Fairfax · A 11 mi de distancia
- Inova Fair Oaks Hospital, Fairfax · A 11 mi de distancia
Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS
ReclutandoFase 1/2
- Next Oncology Virginia, Fairfax · A 11 mi de distancia
A 2-part Phase 1/2 Open-label Trial on ODM-212
ReclutandoFase 1/2
- NEXT Oncology Virginia, Fairfax · A 11 mi de distancia
A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation
ReclutandoFase 1/2
- NEXT Virginia, Fairfax · A 11 mi de distancia
A Phase 1/2 Study of VS-7375 in Patients With KRAS G12D-Mutated Solid Tumors
ReclutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
A Study Evaluating FMC-376 in Participants With KRAS G12C Mutated Solid Tumors
ReclutandoFase 1/2
- Virginia Cancer Specialists, Fairfax · A 11 mi de distancia
Study of CP-383 in Patients With Advanced or Metastatic Solid Tumors
ReclutandoFase 1/2
- NEXT Virginia, Fairfax · A 11 mi de distancia
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
ReclutandoFase 1/2
- NEXT, Virginia, Fairfax · A 11 mi de distancia
Más información sobre Cáncer de páncreas en MedlinePlus
Ensayos de Cáncer de páncreas en otras ciudades
- Houston, TX61 estudios
- New York City, NY60 estudios
- Boston, MA43 estudios
- Nashville, TN39 estudios
- Los Angeles, CA35 estudios
- St. Louis, MO33 estudios
- Baltimore, MD31 estudios
- San Antonio, TX31 estudios
- Philadelphia, PA26 estudios
- Tampa, FL26 estudios
- Durham, NC24 estudios
- San Diego, CA24 estudios
Otros estudios en Arlington
- Cáncer de pulmón de células no pequeñas104 estudios
- Cáncer metastásico53 estudios
- Cáncer del colon y del recto52 estudios
- Cáncer (todos los tipos)48 estudios
- Cáncer de seno47 estudios
- Cáncer de ovario46 estudios
- Cáncer de pulmón41 estudios
- Cáncer de endometrio39 estudios
- Carcinoma de células escamosas de cabeza y cuello26 estudios
- Cáncer de pulmón de células pequeñas23 estudios
- Cáncer de estómago20 estudios
- Cáncer de mama triple negativo20 estudios
De ClinicalTrials.gov, datos obtenidos el 6 oct 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.